These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 19231096)
1. Diagnostic utility of expression of claudins in non-small cell lung cancer: different expression profiles in squamous cell carcinomas and adenocarcinomas. Jung JH; Jung CK; Choi HJ; Jun KH; Yoo J; Kang SJ; Lee KY Pathol Res Pract; 2009; 205(6):409-16. PubMed ID: 19231096 [TBL] [Abstract][Full Text] [Related]
2. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653 [TBL] [Abstract][Full Text] [Related]
3. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Paschoud S; Bongiovanni M; Pache JC; Citi S Mod Pathol; 2007 Sep; 20(9):947-54. PubMed ID: 17585317 [TBL] [Abstract][Full Text] [Related]
4. Claudins 1, 3M, 3S, 4, 5 and 7 in vulvar neoplasms compared with vulvar squamous cell carcinoma. Riski M; Santala M; Soini Y; Talvensaari-Mattila A Tumour Biol; 2012 Apr; 33(2):537-42. PubMed ID: 22170432 [TBL] [Abstract][Full Text] [Related]
5. Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers. Merikallio H; Pääkkö P; Harju T; Soini Y Int J Clin Exp Pathol; 2011; 4(7):667-73. PubMed ID: 22076167 [TBL] [Abstract][Full Text] [Related]
6. Distinct claudin expression profile in histologic subtypes of lung cancer. Moldvay J; Jäckel M; Páska C; Soltész I; Schaff Z; Kiss A Lung Cancer; 2007 Aug; 57(2):159-67. PubMed ID: 17418912 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Lechpammer M; Resnick MB; Sabo E; Yakirevich E; Greaves WO; Sciandra KT; Tavares R; Noble LC; DeLellis RA; Wang LJ Mod Pathol; 2008 Nov; 21(11):1320-9. PubMed ID: 18587324 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related]
10. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Tzelepi VN; Tsamandas AC; Vlotinou HD; Vagianos CE; Scopa CD Mod Pathol; 2008 Jan; 21(1):22-30. PubMed ID: 17962811 [TBL] [Abstract][Full Text] [Related]
11. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005 [TBL] [Abstract][Full Text] [Related]
12. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC). Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722 [TBL] [Abstract][Full Text] [Related]
13. Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells. Zheng Z; Lin K; Hu Y; Zhou Y; Ding X; Wang Y; Wu W Cell Death Dis; 2019 Mar; 10(4):259. PubMed ID: 30874545 [TBL] [Abstract][Full Text] [Related]
14. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma. Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851 [TBL] [Abstract][Full Text] [Related]
15. Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers. Németh Z; Szász AM; Tátrai P; Németh J; Gyorffy H; Somorácz A; Szíjártó A; Kupcsulik P; Kiss A; Schaff Z J Histochem Cytochem; 2009 Feb; 57(2):113-21. PubMed ID: 18854598 [TBL] [Abstract][Full Text] [Related]
16. Slug is associated with poor survival in squamous cell carcinoma of the lung. Merikallio H; T TT; Pääkkö P; Mäkitaro R; Kaarteenaho R; Lehtonen S; Salo S; Salo T; Harju T; Soini Y Int J Clin Exp Pathol; 2014; 7(9):5846-54. PubMed ID: 25337226 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607 [TBL] [Abstract][Full Text] [Related]
18. Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin. Hintsala HR; Siponen M; Haapasaari KM; Karihtala P; Soini Y Int J Clin Exp Pathol; 2013; 6(12):2855-63. PubMed ID: 24294371 [TBL] [Abstract][Full Text] [Related]
19. Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas. Ushiku T; Shinozaki-Ushiku A; Maeda D; Morita S; Fukayama M Histopathology; 2012 Dec; 61(6):1043-56. PubMed ID: 22803571 [TBL] [Abstract][Full Text] [Related]
20. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Soini Y Hum Pathol; 2004 Dec; 35(12):1531-6. PubMed ID: 15619213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]